Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer

Ning Zhang(Chinese Academy of Sciences), Jin‐Xue He(Chinese Academy of Sciences)

Cell Death and Disease

February 15, 2021

10.1038/s41419-021-03475-4

Cited by 32

Related Papers

Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance

|EMBO Molecular Medicine|2023|42

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent <i>in vitro</i> and <i>in vivo</i> anticancer activity, characteristic of high tissue distribution

|Oncotarget|2016|41

GSK3β Inhibition Synergizes with PARP Inhibitors through the Induction of Homologous Recombination Deficiency in Colorectal Cancer

|Research Square|2020|0